Patent · US Active

N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine

US10173988B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

GLUCOX BIOTECH AB · SE

Inventors

Per Wikström · Uppsala, SE
Erik Walum
Mona Wilcke · Stockholm, SE

Key dates

Filing date	Feb 15, 2016
Grant date	Jan 8, 2019
Priority date	—
Expiry date	Feb 15, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The compound N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine or a pharmaceutically acceptable salt of said compound. The compound is useful the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase activity. A pharmaceutical composition comprising the compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.